The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Open accessAbstract
INTRODUCTION: Metabolic syndrome represents a cluster of related metabolic abnormalities, including central obesity, hypertension, dyslipidemia, hyperglycemia, and insulin resistance, with central obesity and insulin resistance in particular recognized as causative factors. These metabolic derangements present significant risk factors for cardiovascular disease, which is commonly recognized as the primary clinical outcome, although other outcomes are possible. Metabolic syndrome is a progressive condition that encompasses a wide array of disorders with specific metabolic abnormalities presenting at different times. These abnormalities can be detected and monitored via serum biomarkers. This review will compile a list of promising biomarkers that are associated with metabolic syndrome and this panel can aid in early detection and management of metabolic syndrome in high risk populations, such as in West Virginia. METHODS: A literature review was conducted using PubMed, Science Direct, and Google Scholar to search for markers related to metabolic syndrome. Biomarkers searched included adipokines (leptin, adiponectin), neuropeptides (ghrelin), pro-inflammatory cytokines (IL-6, TNF-α), anti-inflammatory cytokines (IL-10), markers of antioxidant status (OxLDL, PON-1, uric acid), and prothrombic factors (PAI-1). RESULTS: According to the literature, the concentrations of pro-inflammatory cytokines (IL-6, TNF-α), markers of pro-oxidant status (OxLDL, uric acid), and prothrombic factors (PAI-1) were elevated in metabolic syndrome. Additionally, leptin concentrations were found to be elevated in metabolic syndrome as well, likely due to leptin resistance. In contrast, concentrations of anti-inflammatory cytokines (IL-10), ghrelin, adiponectin, and antioxidant factors (PON-1) were decreased in metabolic syndrome, and these decreases also correlated with specific disorders within the cluster. CONCLUSION: Based on the evidence presented within the literature, the aforementioned biomarkers correlate significantly with metabolic syndrome and could provide a minimally-invasive means for early detection and specific treatment of these disorders. Further research is encouraged to determine the efficacy of applying these biomarkers to diagnosis and treatment in a clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Sontrop, J. M., Dixon, S. N., Garg, A. X., Buendia-Jimenez, I., Dohein, O., Huang, S.-H. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,871
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Oxidative Medicine and Cellular Longevity
(2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2572 · Cited by 2,393
International Journal of Molecular Medicine
(2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm · Cited by 2,246
Circulating Ghrelin Levels Are Decreased in Human Obesity
Tschöp, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E., & Heiman, M. L. (2001) · Diabetes · doi:10.2337/diabetes.50.4.707 · Cited by 2,008
Inflammation, Oxidative Stress, and Obesity
Fernández-Sánchez, A., Madrigal-Santillán, E., Bautista, M., Esquivel-Soto, J., Morales-González, Á., Esquivel-Chirino, C., Durante-Montiel, I., Sánchez-Rivera, G., Valadez-Vega, C., & Morales-González, J. A. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12053117 · Cited by 1,527
Prevalence of the metabolic syndrome in the United States, 2003-2012
Aguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015) · JAMA · doi:10.1001/jama.2015.4260 · Cited by 1,267
Adiponectin and Metabolic Syndrome
Matsuzawa, Y., Funahashi, T., Kihara, S., & Shimomura, I. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000099786.99623.ef · Cited by 1,202
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
Arteriosclerosis, Thrombosis, and Vascular Biology
(2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0b013e31822a51e2 · Cited by 1,109
Johnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T., Feig, D. I., Kang, D.-H., Gersch, M. S., Benner, S., & Sánchez-Lozada, L. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.899 · Cited by 1,075
Biomarkers: Potential uses and limitations
Mayeux, R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.182 · Cited by 916
Howard, W. J. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70316-0 · Cited by 897
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844
Adiponectin as a Biomarker of the Metabolic Syndrome
Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y., & Funahashi, T. (2004) · Circulation Journal · doi:10.1253/circj.68.975 · Cited by 767
Smith, S. C., Jr. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/g1ga-9884 · Cited by 748
European Journal of Clinical Investigation
(2010) · European Journal of Clinical Investigation · doi:10.1111/(issn)1365-2362 · Cited by 632
Beilby, J. P. (2004) · PubMed Central · Cited by 610
Hara, K., Horikoshi, M., Yamauchi, T., Yago, H., Miyazaki, O., Ebinuma, H., Imai, Y., Nagai, R., & Kadowaki, T. (2006) · Diabetes Care · doi:10.2337/dc05-1801 · Cited by 574
Adipokines as novel biomarkers and regulators of the metabolic syndrome
Deng, Y., & Scherer, P. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05875.x · Cited by 558
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534
High plasma uric acid concentration: causes and consequences
de Oliveira, E. P., & Burini, R. C. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-12 · Cited by 501
Ford, E. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.022 · Cited by 501
International Journal of Endocrinology
(2022) · International Journal of Endocrinology · doi:10.1155/1573 · Cited by 501
Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents
Ford, E. S., Li, C., Cook, S., & Choi, H. K. (2007) · Circulation · doi:10.1161/circulationaha.106.657627 · Cited by 497
Leptin and Cardiovascular Disease: Response to Therapeutic Interventions
Koh, K. K., Park, S. M., & Quon, M. J. (2008) · Circulation · doi:10.1161/circulationaha.107.741645 · Cited by 479
Vague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M. C., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000200416.65370.a0 · Cited by 435
Sakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420
Metabolism: Clinical and experimental
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92576-3 · Cited by 418
Fliser, D., Buchholz, K., & Haller, H. (2004) · Circulation · doi:10.1161/01.cir.0000140265.21608.8e · Cited by 404
Inflammation Impairs Reverse Cholesterol Transport In Vivo
McGillicuddy, F. C., de la Llera Moya, M., Hinkle, C. C., Joshi, M. R., Chiquoine, E. H., Billheimer, J. T., Rothblat, G. H., & Reilly, M. P. (2009) · Circulation · doi:10.1161/circulationaha.108.810721 · Cited by 391
PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences
Alessi, M.-C., & Juhan-Vague, I. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000242905.41404.68 · Cited by 390
Rezaie-Majd, A., Maca, T., Bucek, R. A., Valent, P., Müller, M. R., Husslein, P., Kashanipour, A., Minar, E., & Baghestanian, M. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000022694.16328.cc · Cited by 379
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Juhan-Vague, I., Alessi, M.-C., Mavri, A., & Morange, P. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00279.x · Cited by 371 · cited 16×
“The link between PAI-1 and metabolic syndrome has been long established with elevated levels being strongly correlated such that the more severe the metabolic syndrome, the higher the PAI-1 [51-53].”
BackgroundInfluentialSelective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Chenevard, R., Hürlimann, D., Béchir, M., Enseleit, F., Spieker, L., Hermann, M., Riesen, W., Gay, S., Gay, R. E., Neidhart, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051361.69808.3a · Cited by 358
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes
van Exel, E., Gussekloo, J., de Craen, A. J. M., Frölich, M., Bootsma-van der Wiel, A., & Westendorp, R. G. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1088 · Cited by 358
Association of Low Interleukin-10 Levels with the Metabolic Syndrome in Obese Women
Esposito, K., Pontillo, A., Giugliano, F., Giugliano, G., Marfella, R., Nicoletti, G., & Giugliano, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021437 · Cited by 355
Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 339
Leptin Signaling and Obesity: Cardiovascular Consequences
Yang, R., & Barouch, L. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.156596 · Cited by 331
Sola, S., Mir, M. Q. S., Khan, B. V., Lerakis, S., & Tandon, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.088 · Cited by 324
Holvoet, P. (2008) · JAMA · doi:10.1001/jama.299.19.2287 · Cited by 324
Lara-Castro, C., Fu, Y., Chung, B. H., & Garvey, W. T. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814a645f · Cited by 315
Ishizaka, N., Ishizaka, Y., Toda, E.-I., Nagai, R., & Yamakado, M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000161274.87407.26 · Cited by 307
(on behalf of the European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk Study Group), Finucane, F. M., Luan, J., Wareham, N. J., Sharp, S. J., O’Rahilly, S., Balkau, B., Flyvbjerg, A., Walker, M., Højlund, K., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1508-3 · Cited by 302
Oxidative stress and metabolic pathologies: from an adipocentric point of view
Le Lay, S., Simard, G., Martinez, M. C., & Andriantsitohaina, R. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/908539 · Cited by 291
Choi, H. K., Soriano, L. C., Zhang, Y., & Rodriguez, L. A. G. (2012) · BMJ · doi:10.1136/bmj.d8190 · Cited by 278
McLaughlin, T., Abbasi, F., Lamendola, C., Frayo, R. S., & Cummings, D. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031572 · Cited by 274
Rathmann, W., Funkhouser, E., Dyer, A. R., & Roseman, J. M. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00204-4 · Cited by 270
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
Tsouli, S. G., Liberopoulos, E. N., Mikhailidis, D. P., Athyros, V. G., & Elisaf, M. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.013 · Cited by 254
Baratta, R., Amato, S., Degano, C., Farina, M. G., Patanè, G., Vigneri, R., & Frittitta, L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031777 · Cited by 252
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance
Aroor, A. R., McKarns, S., DeMarco, V. G., Jia, G., & Sowers, J. R. (2013) · Metabolism · doi:10.1016/j.metabol.2013.07.001 · Cited by 242
Gullestad, L., Aukrust, P., Ueland, T., Espevik, T., Yee, G., Vagelos, R., Frøland, S. S., & Fowler, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00495-7 · Cited by 240
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
Phillips, S. A., Ciaraldi, T. P., Kong, A. P. S., Bandukwala, R., Aroda, V., Carter, L., Baxi, S., Mudaliar, S. R., & Henry, R. R. (2003) · Diabetes · doi:10.2337/diabetes.52.3.667 · Cited by 226
Folsom, A. R., Qamhieh, H. T., Wing, R. R., Jeffery, R. W., Stinson, V. L., Kuller, L. H., & Wu, K. K. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.162 · Cited by 225
Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles
Binder, B. R., Christ, G., Gruber, F., Grubic, N., Hufnagl, P., Krebs, M., Mihaly, J., & Prager, G. W. (2002) · Physiology · doi:10.1152/nips.01369.2001 · Cited by 225
Athyros, V. G., Elisaf, M., Papageorgiou, A. A., Symeonidis, A. N., Pehlivanidis, A. N., Bouloukos, V. I., Milionis, H. J., & Mikhailidis, D. P. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.023 · Cited by 209
Differential Role of Leptin and Adiponectin in Cardiovascular System
Ghantous, C. M., Azrak, Z., Hanache, S., Abou-Kheir, W., & Zeidan, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/534320 · Cited by 204
Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss
Jung, S. H., Park, H. S., Kim, K.-S., Choi, W. H., Ahn, C. W., Kim, B. T., Kim, S. M., Lee, S. Y., Ahn, S. M., Kim, Y. K., et al. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.05.007 · Cited by 199
Changes of Body Weight and Plasma Ghrelin Levels after Gastric Banding and Gastric Bypass
Stoeckli, R., Chanda, R., Langer, I., & Keller, U. (2004) · Obesity Research · doi:10.1038/oby.2004.43 · Cited by 194
Hyperuricemia, gout and the metabolic syndrome
Puig, J. G., & Martínez, M. A. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f4b1ed · Cited by 194
Costa, L. G., Giordano, G., & Furlong, C. E. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.008 · Cited by 189
Glueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T. R., Weber, K., Illig, E., Streicher, P., Sieve-Smith, L., Tracy, T. M., Lang, J. E., et al. (2001) · Metabolism · doi:10.1053/meta.2001.24192 · Cited by 188
Kruszynska, Y. T., Yu, J. G., Olefsky, J. M., & Sobel, B. E. (2000) · Diabetes · doi:10.2337/diabetes.49.4.633 · Cited by 185
Review of Hyperuricemia as New Marker for Metabolic Syndrome
Billiet, L., Doaty, S., Katz, J. D., & Velasquez, M. T. (2014) · ISRN Rheumatology · doi:10.1155/2014/852954 · Cited by 181
Fructose: A Key Factor in the Development of Metabolic Syndrome and Hypertension
Khitan, Z., & Kim, D. H. (2013) · Journal of Nutrition and Metabolism · doi:10.1155/2013/682673 · Cited by 180
Relationship between hyperuricemia and metabolic syndrome
Chen, L.-Y., Zhu, W.-H., Chen, Z.-W., Dai, H.-L., Ren, J.-J., Chen, J.-H., Chen, L.-Q., & Fang, L.-Z. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0593 · Cited by 168
Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages
Hyun, B., Shin, S., Lee, A., Lee, S., Song, Y., Ha, N., Cho, K., & Kim, K. (2013) · Immune Network · doi:10.4110/in.2013.13.4.123 · Cited by 155
Hayek, T. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00239-4 · Cited by 147
Rector, R. S., Warner, S. O., Liu, Y., Hinton, P. S., Sun, G. Y., Cox, R. H., Stump, C. S., Laughlin, M. H., Dellsperger, K. C., & Thomas, T. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2007 · Cited by 147
Sigurdardottir, V., Fagerberg, B., & Hulthe, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01054.x · Cited by 144
Landar, A. L., Żmijewski, J. W., Dickinson, D. A., Goffe, C. L., Johnson, M. S., Milne, G. L., Zanoni, G., Vidari, G., Morrow, J. D., & Darley-Usmar, V. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01087.2005 · Cited by 140
Salivary uric acid as a noninvasive biomarker of metabolic syndrome
Soukup, M., Biesiada, I., Henderson, A. T., Idowu, B., Rodeback, D., Ridpath, L. C., Bridges, E. G., Nazar, A. M., & Bridges, K. G. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-14 · Cited by 140
Elkan, A., Sjöberg, B. G., Kolsrud, B., Ringertz, B., Hafström, I., & Frostegård, J. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2388 · Cited by 136
Gannagé‐Yared, M., Khalifé, S., Semaan, M., Fares, F., Jambart, S., & Halaby, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02175 · Cited by 136
Opposite Regulation of the Human Paraoxonase-1 Gene PON-1 by Fenofibrate and Statins
Gouédard, C., Koum-Besson, N., Barouki, R., & Morel, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.945 · Cited by 132
Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome
Choi, K. M., Ryu, O., Lee, K., Kim, H., Seo, J. A., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.019 · Cited by 129
Bhandari, R., Kelley, G. A., Hartley, T. A., & Rockett, I. R. H. (2014) · International Journal of Breast Cancer · doi:10.1155/2014/189384 · Cited by 125
Low plasma adiponectin concentration is an indicator of the metabolic syndrome
Santaniemi, M., Kesäniemi, Y. A., & Ukkola, O. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02287 · Cited by 117
St-Pierre, D. H., Karelis, A. D., Coderre, L., Malita, F. M., Fontaine, J., Mignault, D., Brochu, M., Bastard, J., Cianflone, K., Doucet, É., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1603 · Cited by 111
Weiss, T., Arnesen, H., & Seljeflot, I. (2013) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2013.01.019 · Cited by 109
Vasankari, T. J., Ahotupa, M. O., Toikka, J., Mikkola, J., Irjala, K. M. A., Pasanen, P., Neuvonen, K., Raitakari, O. T., & Viikari, J. S. A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00573-6 · Cited by 104
Tsunoda, S., Kamide, K., Minami, J., & Kawano, Y. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02953-9 · Cited by 101
DeRijk, R. H., Petrides, J. S., Deuster, P. A., Gold, P. W., & Sternberg, E. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550757 · Cited by 100
Fagerberg, B., Hultén, L. M., & Hulthe, J. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00274-9 · Cited by 98
Ghrelin and lipid metabolism: key partners in energy balance
Varela, L., Vazquez, M. J., Cordido, F., Nogueiras, R., Vidal‐Puig, A., Diéguez, C., & López, M. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0068 · Cited by 97
Stelmach, I., Jerzyńska, J., & Kuna, P. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01286.x · Cited by 93
Tesauro, M., Schinzari, F., Rovella, V., Daniele, N. D., Lauro, D., Mores, N., Veneziani, A., & Cardillo, C. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.137729 · Cited by 92
Ghrelin Suppression in Overweight Children: A Manifestation of Insulin Resistance?
Bacha, F. F., & Arslanian, S. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1582 · Cited by 90
Ghrelin in Diabetes and Metabolic Syndrome
Pulkkinen, L., Ukkola, O. H., Kolehmainen, M., & Uusitupa, M. I. J. (2010) · International Journal of Peptides · doi:10.1155/2010/248948 · Cited by 87
Beneficial effects of statins in patients with non-ischemic heart failure
Laufs, U., Waßmann, S., Schackmann, S., Heeschen, C., B�hm, M., & Nickenig, G. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-1005-0 · Cited by 86
Gambineri, A., Pagotto, U., Tschöp, M., Vicennati, V., Manicardi, E., Carcello, A., Cacciari, M., Iasio, R. D., & Pasquali, R. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347020 · Cited by 86
Estrogen Replacement Therapy Increases Plasma Ghrelin Levels
Kellokoski, E., Pöykkö, S. M., Karjalainen, A. H., Ukkola, O. H., Heikkinen, J. E., Kesäniemi, Y. A., & Hörkkö, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2016 · Cited by 86
Kadoglou, N. P. E., Tsanikidis, H., Kapelouzou, A., Vrabas, I. S., Vitta, I., Karayannacos, P. E., Liapis, C. D., & Sailer, N. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.005 · Cited by 78
Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations
Yun, J. E., Kimm, H., Jo, J., & Jee, S. H. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.012 · Cited by 77
Clausen, J. O., Borch‐Johnsen, K., Ibsen, H., & Pedersen, O. B. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380063 · Cited by 76
Low plasma ghrelin concentration is an indicator of the metabolic syndrome
Ukkola, O. H., Pöykkö, S. M., & Kesäniemi, Y. A. (2006) · Annals of Medicine · doi:10.1080/07853890600622192 · Cited by 75
What is the best biomarker for metabolic syndrome diagnosis?
Falahi, E., Rad, A., & Roosta, S. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.06.014 · Cited by 73
Krakauer, M., Sørensen, P. S., Khademi, M., Olsson, T. P., & Sellebjerg, F. T. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507087136 · Cited by 73
Plasminogen activator inhibitor-1 in kidney pathology
Małgorzewicz, S., Skrzypczak‐Jankun, E., & Jankun, J. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1234 · Cited by 71
Effects of Preoperative Statin Therapy on Cytokines after Cardiac Surgery
Liakopoulos, O. J., Dörge, H., Schmitto, J. D., Nagorsnik, U., Grabedünkel, J., & Schöndube, F. A. (2006) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-2006-923836 · Cited by 69
Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?
Kraja, A. T., Province, M. A., Arnett, D. K., Wagenknecht, L. E., Tang, W., Hopkins, P. N., Djoussé, L., & Borecki, I. B. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-28 · Cited by 69
Comaschi, M., & Menozzi, F. (2001) · PubMed · Cited by 67
Dong, M., & Ren, J. T. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282004140213160930 · Cited by 65
Cong, W., Golden, E., Pantaleo, N., White, C. M., Maudsley, S. R., & Martin, B. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361513 · Cited by 64
Yoshinaga, M., Sameshima, K., Tanaka, Y., Wada, A., Hashiguchi, J., Tahara, H., & Kono, Y. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0180 · Cited by 63
Relationship between leptin and body mass and metabolic syndrome in an adult population
Martins, M. D. C., Faleiro, L. L., & Fonseca, A. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2012.09.008 · Cited by 62
Indulekha, K., Surendar, J., & Mohan, V. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500421 · Cited by 59
Görmez, S., Demirkan, A., Atalar, F., Çaynak, B., Erdim, R., Sözer, V., Günay, D., Akpinar, B., Özbek, U., & Buyukdevrim, A. S. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4753 · Cited by 58
Ghrelin and Metabolic Disorders
Ukkola, O. H. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309787315220 · Cited by 57
Biomarkers: Potential uses and limitations
Mayeux, R. P. (2004) · Neurotherapeutics · doi:10.1007/bf03206601 · Cited by 57
Chedraui, P. A., Escobar, G. S., Pérez-López, F. R., Palla, G., Guevara, M. M. M., Cecchi, E., Genazzani, A. R., & Simoncini, T. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.01.014 · Cited by 56
Fogari, R., Derosa, G., Zoppi, A., Rinaldi, A., Lazzari, P., Fogari, E., Mugellini, A., & Preti, P. S. (2005) · Hypertension Research · doi:10.1291/hypres.28.209 · Cited by 55
Interleukin-10 Associates With Adiponectin Predominantly in Subjects With Metabolic Syndrome
Nishida, M., Moriyama, T., Sugita, Y., & Yamauchi‐Takihara, K. (2007) · Circulation Journal · doi:10.1253/circj.71.1234 · Cited by 53
Samuelsson, L., Gottsäter, A., & Lindgärde, F. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00264.x · Cited by 53
Distribuição por gênero de ácido úrico sérico e fatores de risco cardiovascular: estudo populacional
Rodrigues, S. L., Baldo, M. P., Capingana, P., et al. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 52
Proinflammatory effects of malondialdehyde in lymphocytes
Raghavan, S., Subramaniyam, G., & Shanmugam, N. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211617 · Cited by 51
Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents.
Calcaterra, V., AMICI, M. D., Klersy, C., Torre, C., Brizzi, V., Scaglia, F., Albanesi, M., Albertini, R., Allais, B., & Larizza, D. (2009) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 50
Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction
Thøgersen, A. M., Söderberg, S., Jansson, J., Dahlén, G. H., Boman, K., Nilsson, T., Lindahl, B., Weinehall, L., Stenlund, H. C., Lundberg, V., et al. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000116824.84388.a2 · Cited by 50
Cardiac hypertrophy: stressing out the heart
Tardiff, J. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28884 · Cited by 49
Koh, K. K., Quon, M. J., Lee, S. J., Han, S. H., Ahn, J. Y., Kim, J., Chung, W., Lee, Y., & Shin, E. K. (2007) · Diabetes Care · doi:10.2337/dc06-2267 · Cited by 47
Kim, S. G., Ryu, O. H., Kim, H. Y., Lee, K. W., Seo, J. A., Kim, N. H., Choi, K. M., Lee, J., Baik, S. H., & Cho, Y. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02100 · Cited by 47
Krzystek‐Korpacka, M., Patryn, E., Hotowy, K., Czapińska, E., Majda, J., Kustrzeba−Wójcicka, I., Noczyńska, A., & Gamian, A. (2013) · PubMed · Cited by 46
Viazzi, F. C., Garneri, D., Leoncini, G., Gonnella, A., Muiesan, M. L., Ambrosioni, E., Costa, F. V., Leonetti, G., Pessina, A. C., Trimarco, B., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.018 · Cited by 44
Activation of Dopamine D2 Receptors Lowers Circadian Leptin Concentrations in Obese Women
Kok, P., Roelfsema, F., Frölich, M., PELT, J. V., Meinders, A. E., & Pijl, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2529 · Cited by 43
Relação entre a leptina, a massa corporal e a síndrome metabólica numa amostra da população adulta
Martins, M. D. C., Faleiro, L. L., & Fonseca, A. (2012) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2012.08.002 · Cited by 42
Leptin:Adiponectin Ratio and Metabolic Syndrome in the General Japanese Population
Kotani, K., & Sakane, N. (2011) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2011.31.3.162 · Cited by 37
Association between metabolic syndrome and serum leptin levels in postmenopausal women
Lee, S. W., Jo, H., Kim, J.-H., You, Y. O., & Kim, J. H. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.618893 · Cited by 36
Paganelli, F. F., Alessi, M., Morange, P., Maixent, J. M., Lévy, S., & Juhan-Vague, I. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614637 · Cited by 36
Production of interleukin-10 in asthmatic children after Beta-1-3-glucan
SARINHO, E. S. C., Medeiros, D., Schor, D., Silva, A. R., Sales, V. S. D. F., Motta, M. E., da Costa, A. C., Azoubel, A., & Rizzo, J. Â. (2009) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2009.02.005 · Cited by 35
Martinelli, N., Micaglio, R., Consoli, L., Guarini, P., Grison, E., Pizzolo, F., Friso, S., Trabetti, E., Pignatti, P. F., Corrocher, R., et al. (2011) · Experimental Diabetes Research · doi:10.1155/2012/231502 · Cited by 33
Pohjantähti‐Maaroos, H., Palomäki, A., Kankkunen, P., Laitinen, R., Husgafvel, S., & Oksanen, K. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-41 · Cited by 29
von Eynatten, M., Liu, D., Bluemm, A., Schuster, T., Baumann, M., Lutz, J., Heemann, U. W., Dugi, K. A., Nawroth, P. P., Bierhaus, A., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03412.x · Cited by 26
Fogari, R., Zoppi, A., Mugellini, A., Maffioli, P., Lazzari, P., & Derosa, G. (2011) · Hypertension Research · doi:10.1038/hr.2011.137 · Cited by 26
Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity
Turfaner, N., Uzun, H., Balcı, H., et al. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181d83374 · Cited by 25
Bilgili, S., Çelebiler, A., Aylin, D., et al. (2008) · PubMed · Cited by 25
Wójcicka, G., Jamróz-Wiśniewska, A., Marciniak, A., Łowicka, E., & Bełtowski, J. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.05.018 · Cited by 21
Huang, F., Del-Rio-Navarro, B. E., Ontiveros, J. A. P., Ruíz-Bedolla, E., Saucedo-Ramírez, O. J., Villafaña, S., Bravo, G., Mailloux‐Salinas, P., & Hong, E. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0157 · Cited by 21
Ihara, S., Shimamoto, K., Watanabe, H., SAKAI, R., & Kawana, M. (2006) · Hypertension Research · doi:10.1291/hypres.29.805 · Cited by 20
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Delkos, D., Tsourdi, E. A., & Panidis, D. (2013) · HORMONES · doi:10.14310/horm.2002.1444 · Cited by 20
Ficek, J., Kokot, F., Chudek, J. T., et al. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-38247 · Cited by 19
Li, C., Zhang, J.-Y., Yu, D. M., & Zhang, Q.-M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-41 · Cited by 18
Cicero, A. F. G., Magni, P., Morè, M., Ruscica, M., Borghi, C., & Strollo, F. (2012) · Obesity Facts · doi:10.1159/000339575 · Cited by 17
Lee, J.-M., Kim, J.-H., Hs, S., Hong, E.-G., Yu, J.-M., Han, K.-A., Min, K.-W., & Chang, S.-A. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800128 · Cited by 17
The influence of chosen adipocytokines on blood pressure values in patients with metabolic syndrome.
Musialik, K. (2012) · PubMed · Cited by 16
Sam, S., Haffner, S. M., Davidson, M. H., D’Agostino, R. B., Pérez, A., & Mazzone, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1699 · Cited by 15
Changes in adiponectin level and fat distribution in patients with type 2 diabetes
Miazgowski, T., Dziwura, J., Safranow, K., Iskierska, K., & Widecka, K. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12207 · Cited by 13
Eplerenone administration has beneficial effect on hepatic paraoxonase 1 activity in diabetic mice
Noll, C., Messaoudi, S., Milliez, P., Samuel, J., Delcayre, C., & Janel, N. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.038 · Cited by 5
Meriç, C., Aydoğdu, A., Taşçı, İ., Denız, F., Baysal, O., Serdar, M. A., Sağlam, K., & Azal, Ö. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.4738 · Cited by 4
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Metadata
- Authors
- Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K.
- Venue
- International Journal of Medical Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2016
- Volume
- 13
- Issue
- 1
- Pages
- 25-38
- ISSN
- 1449-1907 (ISSN-L)
- OpenAlex
- W2337535033
- Cited by
- 443
- References
- 154
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.